Infliximab-Induced Autoimmune Hepatitis with Successful Switch to Adalimumab in a Patient with Crohn’s disease: The Index Case

被引：0
作者：
Dahlia A. Goldfeld
Elizabeth C. Verna
Jay Lefkowitch
Arun Swaminath
机构：
[1] Columbia University Graduate School of Arts and Sciences,Division of Gastroenterology, Department of Medicine
[2] Columbia University Medical Center,Department of Pathology
[3] Columbia University Medical Center,undefined
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Crohn’s disease; Anti-TNF agents; Infliximab; Adalimumab; Autoimmune hepatitis; Drug-induced hepatitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3386 / 3388
页数：2
相关论文
共 17 条
[1]  
Sokolove J(2010)Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis Ann Rheum Dis 69 1612-1617
[2]  
Strand V(2008)Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 169-176
[3]  
Greenberg JD(2010)Hepatotoxicity of agents used in the management of inflammatory bowel disease Dig Dis 28 508-518
[4]  
Hennes EM(2010)Infliximab-related hepatitis: discussion of a case and review of the literature Intern Emerg Med 5 193-200
[5]  
Zeniya M(2010)Infliximab-induced acute hepatitis during Crohn’s disease therapy: Absence of cross-toxicity with adalimumab Gastroenterologie Clinique et Biologique 34 e7-e8
[6]  
Czaja AJ(undefined)undefined undefined undefined undefined-undefined
[7]  
Khokhar OS(undefined)undefined undefined undefined undefined-undefined
[8]  
Lewis JH(undefined)undefined undefined undefined undefined-undefined
[9]  
Mancini S(undefined)undefined undefined undefined undefined-undefined
[10]  
Amorotti E(undefined)undefined undefined undefined undefined-undefined
12